A NEW IDEA ON BLUEPRINT MEDICINE $BPMC $IBB $XBI $BBH $BIS
This post was just published on ZYX Buy Change Alert.
BPMC is a biotech firm focused on developing cancer treatment therapies. This is a new IPO. It is a high risk high reward situation suitable only for aggressive investors as the risk of loss is high.
Here is the plan:
Consider buying a 5% tranche in the zone of $22.00 to $23.50. It is trading at $23 as of this writing. Consider buying a 10% tranche in the zone of $21.00 to $21.67; another 10% tranche in the zone of $20 to $20.37. 10% in the zone of $19.00 to $19.31 and 20% at $18.00 to $18.57.… Please click here or the title below to read more.
April 30, 2015
